
Clinical Trials for Newly Diagnosed Myeloma Patients with John Rosengard
May 26, 2022
07:00PM - 08:00PM EDT
Online Event
Clinical Trials are often considered for those at the end of their treatment who are in need of novel therapies. But is there a need for newly diagnosed patients to participate in clinical trials as well? Come hear the patient experience of myeloma patient, John Rosengard, who participated in the GRIFFIN trial when he was newly diagnosed.
Agenda
07:00 PM
Introduction
Audrey Burton-Bethkee
Audrey introduces the agenda of the event and featured speaker Dr. John Rosengard.
07:05 PM
Presentation
John Rosengard
Josh talks about participating in the GRIFFIN trial when he was newly diagnosed.
07:35 PM
Questions and Answers
Audience
Type your questions in the chat and we will answer them!

Audrey Burton-Bethke

John Rosengard

Todd Foster